Shaun Foy

Biotech | Venture Capital | Founder @crisprtx and @ersgenomics | Canadian / Brit | Adventurer | Canucks Fan! Instagram: shaun.foy

[Mark Carney @MarkJCarney]

Canada will match the new U.S. tariffs dollar for dollar.

In addition, we are introducing $7.5 billion in new and enhanced measures to support Canadian workers and businesses. That builds on the nearly $25 billion in supports introduced since the implementation of the U.S. unjustified tariffs.

Defending Canadian jobs, industries, and families.

Read more:
https://t.co/7m8C6HlLU2

[Gordon Ramsay @GordonRamsay]

An important #FathersDay message from me…WEAR A HELMET ! This week I had a bad accident while riding my bike in CT. I'm doing ok and I’m thankful for all the doctors, nurses and staff at @LMHospital who looked after me but most thankful for my helmet that saved my life. Be Safe

[Bill Ackman @BillAckman]

It is time for us all to boycott the Maldives @thisismaldives.

[CRISPR Therapeutics @CRISPRTX]

In collaboration with Vertex Pharmaceuticals, we're pleased to share that we’ve published three new publications in The New England Journal of Medicine (NEJM) containing clinical data on the treatment for sickle cell disease and beta thalassemia.

[CRISPR Therapeutics @CRISPRTX]

#Breaking: The European Commission approves CRISPR/Cas9 gene-edited treatment, co-developed with Vertex Pharmaceuticals, for #SickleCellDisease and #BetaThalassemia for the European Union. Learn more: https://t.co/94JrUPfhMT

[Bruce Booth @LifeSciVC]

Inverse correlation between Fed rate expectations and the $XBI is so striking. Cost of capital depends on fed rates, making it such a powerful macro decelerant/accelerant for the sector.

Great chart from Jack Bannister at Leerink:

[Biotech Hangout @BiotechCH]

If you’re a listener of Biotech Hangout, please rate the show on Spotify. The show is available on Spotify & podcasts (with a few days delay due to Twitter/X policies) https://t.co/CfV6NHEQ0r

[Ned Pagliarulo @NedPagliarulo]

A long read from me on how Casgevy came to be:

‘No tolerance for failure’: An oral history of the first CRISPR medicine https://t.co/YeSbTakJCH

[Shaun Foy @shaun_foy]

Great article by @NedPagliarulo outlining the journey of Casgevy from the creation of @crisprtx to drug approval. Truly an epic accomplishment by the teams at CRISPR Therapeutics and Vertex. Many lessons from our journey but the most critical for me is the importance of focus.

[Ned Pagliarulo @NedPagliarulo]

A long read from me on how Casgevy came to be:

‘No tolerance for failure’: An oral history of the first CRISPR medicine https://t.co/YeSbTakJCH

[Shaun Foy @shaun_foy]

@evamariadiehl @VertexPharma @CRISPRTX @e__charpentier @rodgernovak Thanks Eva-Maria! It is so exciting to see the approval and know that it will have a major impact for so many patients.

[Shaun Foy @shaun_foy]

@bradloncar @NedPagliarulo With european founders and science out of sweden.

[Robert Nelsen @rtnarch]

It is great to see the President recognize academic medical innovation, and the eventual impact on patients. Left out one BIG thing: Without massive private venture capital and other private funding based on strong patents, both these drugs would not exist. At all. Zero. None.

[Ned Pagliarulo @NedPagliarulo]

Launch prices for one-time gene therapies in the U.S., since this Nov. 2022 tweet:

Roctavian, for hemophilia A - $2,900,000
Elevidys, for Duchenne - $3,200,000
Casgevy, for sickle cell - $2,200,000
Lyfgenia, for sickle cell - $3,100,000

[CRISPR Therapeutics @CRISPRTX]

#Breaking: The U.S. FDA approves the CRISPR/Cas9 gene-edited treatment, co-developed with Vertex Pharmaceuticals, for #SickleCellDisease. Learn more: https://t.co/5U9n8WnoV6

[Kiran Musunuru @kiranmusunuru]

A #CRISPR milestone - the first U.S. FDA approval of a gene-editing therapy!

Here’s a quick recap of the story of how it came to be:

“How CRISPR + GWAS Cured Sickle Cell Disease”

🧵

https://t.co/AQU2Jm07t7

[Kevin Davies @KevinADavies]

Bahrain makes medical history: First in Mideast to approve revolutionary #CRISPR sickle cell treatment, Casgevy
https://t.co/z9sKsoaSxY #bahrain

[CRISPR Therapeutics @CRISPRTX]

Today, we provided an update on our immuno-oncology pipeline of CRISPR/Cas9 gene-edited allogeneic chimeric antigen receptor (CAR) T cell product candidates and we announced expansion into autoimmune disease. Learn more here: https://t.co/IvhNHCj3rm

[nature @Nature]

In a world first, the UK medicines regulator has approved a therapy that uses CRISPR gene editing as a treatment for diseases https://t.co/Lk7eZ4Tkiz

[Shaun Foy @shaun_foy]

Congratulations to the amazing team at Crispr Therapeutics for this landmark achievement!!!

[CRISPR Therapeutics @CRISPRTX]

The UK Medicines and Healthcare products Regulatory Agency approves the CRISPR/Cas9 gene-edited treatment for #SickleCellDisease & #BetaThalassemia in Great Britain. This is a historic milestone arising out of our collaboration with Vertex. Learn more: https://t.co/XiHsNfOZGA

[CRISPR Therapeutics @CRISPRTX]

Ready to be at the forefront of #geneediting? We’re hiring a Gene Editing Innovator in Boston to drive research initiatives and help us continue building cutting-edge #CRISPR technologies. Learn more about this opportunity here: https://t.co/KD7ozO0Hph.